Induced Proximity: Emerging Technologies and Clinical Translation

Feb 07–10, 2028 | Keystone Resort, Keystone, CO, United States
Scientific Organizers: Georg E. Winter, Michael A. Erb, and Gwenn M Hansen

  Livestream
  In Person
  On Demand
×

-

Feb 07–10, 2028 | Keystone Resort, Keystone, CO, United States

Scientific Organizers: Georg E. Winter, Michael A. Erb, and Gwenn M Hansen

Supported by:  
Important Deadlines
Early Registration Deadline: Deadlines not yet available for this meeting.
Scholarship Deadline: Deadlines not yet available for this meeting.
Short Talk Abstract Deadline: Deadlines not yet available for this meeting.
Poster Abstract Deadline: Deadlines not yet available for this meeting.
Meeting Summary

Induced proximity represents a transformative therapeutic paradigm that is revolutionizing drug discovery by offering new modes of controlling protein function beyond traditional inhibition. Targeted protein degradation (TPD), a modality focused on small molecules that induce proximity between disease-relevant target proteins and E3 ubiquitin ligases, best illustrates the power of this emerging field. However, TPD represents only a small fraction of the opportunity space offered by proximity-inducing medicines.


This Keystone Symposia conference on Induced Proximity: Emerging Technologies and Clinical Translation aims to showcase the latest technological innovations and therapeutic developments in the field. Central to the conference are the emerging frontiers of AI-enabled design, alongside the development of novel chemical tools and technological platforms for discovery and precise modulation. Specific sessions will highlight emerging clinical data and summarize the lessons learned from the translation of small molecule degraders into therapeutics.


By integrating experts in AI-driven design, chemical biology, and clinical development, the conference will create a unique platform where established pioneers and rising researchers from academia and industry define the next frontier of proximity-based biology. The conference will feature a shared keynote and plenary session with the joint Keystone Symposia conference on Ubiquitin: New Frontiers in Signaling and Cellular Regulation, while also reporting on the molecular mechanisms of chemical inducers of proximity (CIPs) that rewire protein function to induce novel biological outcomes beyond degradation.


The program’s core goal is to address the pressing challenges of transitioning the discovery of CIPs from serendipity to rational design and of translating these complex modalities into human therapeutics. The cross-disciplinary engagement at this conference will equip attending scientists with mechanistic and translational frameworks, inspiring the collaborations required to deliver the next wave of breakthroughs in non-traditional modalities for targeting disease.


Unique Career Development Opportunities

This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives

KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS

Subscribe for Updates